000			01941 a2200529 4500
005			20250515130029.0
264		0	_c20090206
008			200902s 0 0 eng d
022			_a0028-3908
024	7		_a10.1016/j.neuropharm.2008.06.038 _2doi
040			_aNLM _beng _cNLM
100	1		_aLopez, Sebastien
245	0	0	_aFunctional interaction between adenosine A2A and group III metabotropic glutamate receptors to reduce parkinsonian symptoms in rats. _h[electronic resource]
260			_bNeuropharmacology _cSep 2008
300			_a483-90 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdenosine A2 Receptor Antagonists
650	0	4	_aAnimals
650	0	4	_aBehavior, Animal _xdrug effects
650	0	4	_aCatalepsy _xchemically induced
650	0	4	_aCyclopentanes _xpharmacology
650	0	4	_aDisease Models, Animal
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Combinations
650	0	4	_aHaloperidol
650	0	4	_aMale
650	0	4	_aMotor Activity _xdrug effects
650	0	4	_aOxidopamine _xpharmacology
650	0	4	_aParkinsonian Disorders _xdrug therapy
650	0	4	_aPyridines _xadministration & dosage
650	0	4	_aRats
650	0	4	_aRats, Wistar
650	0	4	_aReaction Time _xdrug effects
650	0	4	_aReceptors, Adenosine A2 _xphysiology
650	0	4	_aReceptors, Metabotropic Glutamate _xagonists
650	0	4	_aTricarboxylic Acids _xpharmacology
650	0	4	_aXanthines _xadministration & dosage
700	1		_aTurle-Lorenzo, Nathalie
700	1		_aJohnston, Tom H
700	1		_aBrotchie, Jonathan M
700	1		_aSchann, Stephan
700	1		_aNeuville, Pascal
700	1		_aAmalric, Marianne
773	0		_tNeuropharmacology _gvol. 55 _gno. 4 _gp. 483-90
856	4	0	_uhttps://doi.org/10.1016/j.neuropharm.2008.06.038 _zAvailable from publisher's website
999			_c18106333 _d18106333